Device Trial Radar · NCT05873387
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Last checked: Nov 20, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,420
Planned (sponsor's estimate)
Start
Jul 12, 2023
Primary completion
May 31, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- Eko Devices, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 24, 2023
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
Conditions
- Pulmonary Hypertension
Interventions
Use of Eko DUO stethoscope (paired ECG/PCG)Device
Auscultation of heart sounds using electronic stethoscope
Primary outcomes
What the sponsor says the trial is designed to measure.
- Build a database of matched ECG/PCG recordings labeled against RHCs and echocardiogramsTime frame: Up to 2 years to complete database
- Develop and clinically test a deep learning algorithm that can detect PH and stratify its severityTime frame: Up to 3 years to complete algorithm development
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Rhode Island Hospital
Providence, Rhode Island · Suspended
The Miriam Hospital
Providence, Rhode Island · Suspended
Providence VA Medical Center
Providence, Rhode Island · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.